Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

Pulmonary infections in critically ill patients are common and are associated with high morbidity and mortality. Piperacillin–tazobactam is a frequently used therapy in critically ill patients with pulmonary infection. Antibiotic concentrations in the lung reflect target‐site antibiotic concentratio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Felton, T W, McCalman, K, Malagon, I, Isalska, B, Whalley, S, Goodwin, J, Bentley, A M, Hope, W W
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2014
Matèries:
Clinical Trial
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169708/
https://ncbi.nlm.nih.gov/pubmed/24926779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.131
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars